{ NEWS AND PRODUCT UPDATE } OptiLube Active CHG Free – Improving patient outcomes and answering clinical demand Optimum Medical has recently launched a new catheterisation jelly - OptiLube Active CHG Free. Born out of clinician demand, OptiLube Active CHG Free is the ideal choice for patients where the use of Chlorhexidine is contraindicated, while maintaining the added benefits of the local anaesthetic (Lidocaine 2%). Evidence demonstrates that repeated exposure to Chlorhexidine can lead to an increased risk of sensitisation, resulting in allergic reactions*. With many Trusts across the UK now implementing Chlorhexidine allergy policies, there was an increasing clinical demand for a catheterisation jelly without this active ingredient. OptiLube Active CHG Free joins Optimum Medical’s existing range of catheterisation jelly syringes - OptiLube Active (with Lidocaine 2% and Chlorhexidine Gluconate 0.25%) and OptiLube (without active ingredients) – providing clinicians with the widest choice currently available in the UK market. Each of these single-use catheterisation jelly syringes are sterile and individually wrapped, coating the full length of the urethra in lubricant and ensuring an aseptic procedure is achieved. Each syringe in the range is designed to improve patient outcomes through minimising the risk of pain, trauma and infection. For Trusts that switch to using any of our catheterisation jellies, we’re able to provide training and education support to ensure a smooth transition. To find out more, please contact us using the details below. *University Hospital of South Manchester (2013). Contact: Optimum Medical T: +44 (0)845 643 5479 E: enquiries@optimummedical.co.uk www.optimummedical.co.uk Innovative, closed instillation system for Mitomycin launched by Medac As part of their continued bladder cancer care programme, medac GmbH has developed a closed instillation system which is supplied as standard with Mitomycin for the treatment of non- muscle invasive bladder cancer (NMIBC). Available from 1 October 2016, this is a new advance in the treatment of NMIBC as it offers healthcare professionals a system which is designed to be easy to use and therefore speed up the process of Mitomycin instillation therapy as well as prevent the possibility of cytotoxic contamination. Mitomycin is indicated for intravesical administration to prevent relapse in adult patients with superficial urinary bladder carcinoma following transurethral resection. Available in 20mg and 40mg vials complete with instillation set, Mitomycin can be administered as both induction and maintenance therapy. Medac has also introduced the NMIBC toolbox; an online, interactive aid for the use of EAU guidelines which is available to download. Contact: medac GmbH T: +44 (0)1786 458086 E: info@medac-uk.co.uk www.medacuk.com BBS Revolution™ bladder scanner BBS Revolution™ with wireless probe for better bladder scanning www.urologynews.uk.com The BBS Revolution™ introduced by Win Health Medical Ltd is described as a truly ‘next generation’ bladder scanner designed for use by medical professionals at all levels, including nurses, paramedics, nursing assistants and carers. The BBS Revolution™ is designed to be easy to use and the easiest to maintain diagnostic ultrasound bladder scanner on the global healthcare market. Technologically advanced and extra practical, the BBS Revolution™ does not need servicing and automatically calibrates itself with every use, ruling out the inconvenience of annual calibration. Bare minimum operator training delivers results everyone can trust. Affordable and long-term cost-effective, the BBS Revolution™ improves user efficiency, reduces scanning time and reduces running costs! Utilising breakthrough patented ultrasound technology with sophisticated imaging capabilities and equipped with a wireless scanning probe, the BBS Revolution™ automatically differentiates between male and female anatomy and locates the bladder without aiming. Accurate and consistently repeatable bladder volume measurements are delivered at a press of the button in just three seconds. Using the BBS Revolution™ is fast and simple and produces accurate and reliable measurements. There is no need for mode selection or aiming of the probe – just a few simple steps deliver the result: • Lift the wireless probe • Apply ample amount of gel • Place the probe firmly on the lower abdomen • Press the button to take the measurement • View the result – the result that you can trust! Wireless scanning probe takes measurements at a distance from the base unit, allowing effective scanning without the console on the trolley entering the patient’s room, thus delivering maximum convenience and highly desirable hygiene benefits. The BBS Revolution™ features innovative patented technology that is entirely unique, distinct and unrelated to other bladder scanner brands, designs and intellectual properties. BBS Revolution™ complies with the MDD 93/42/EEC (CE 0120) and is FDA cleared. Contact: Win Health Medical Ltd T: + 44 (0)1835 864866 F: + 44 (0)1835 268136 E: info@win-health.com www.win-health.com UROLOGY NEWS l V20(6) l September / October 2016 47